title: Invasive fungal infections in patients with chronic granulomatous disease.
abstract: Invasive fungal infections are a major threat for chronic granulomatous disease (CGD) patients. The present study provides a comprehensive overview of published invasive fungal infections in the CGD host through an extensive review of epidemiological, clinical, diagnostic and therapeutic data. In addition to the often mild clinical presentation, the currently used diagnostics for invasive aspergillosis have low sensitivity in CGD patients and cannot be easily translated to this non-neutropenic host. Aspergillus fumigatus and A. nidulans are the most commonly isolated species. A. nidulans infections are seldom reported in other immunocompromised patients, indicating a unique interaction between this fungus and the CGD host. The occurrence of mucormycosis is mainly noted in the setting of treatment of inflammatory complications with immunosuppressive drugs. Candida infections are infrequently seen and do not cause mucocutaneous disease but do show an age-dependent clinical presentation. The CGD patient is susceptible to a wide range of fungal pathogens, indicating the need to determine the causative fungus, often by invasive diagnostics, to guide optimal and rational treatment. This review summarizes current understanding of invasive fungal infections in patients with CGD and will serve as a starting point to guide optimal treatment strategies and to direct further research aimed at improving outcomes.
authors: Department of Pediatric Infectious Diseases and Immunology, Nijmegen Institute for Infection, Inflammation and Immunity, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. S.Henriet@cukz.umcn.nl
authors: Stefanie
authors: S
authors: Henriet
authors: Paul E
authors: PE
authors: Verweij
authors: Steven M
authors: SM
authors: Holland
authors: Adilia
authors: A
authors: Warris
mesh_terms: D006105:Granulomatous Disease, Chronic / Q000150:complications* / Q000382:microbiology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D009181:Mycoses / Q000150:complications* / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D016896:Treatment Outcome